Winner Medical Co., Ltd. (SHE: 300888)

Winner Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3,918	4,706	4,527	4,274	4,163	480.84
Short-Term Investments	-	97.79	101.67	50.16	-	-
Trading Asset Securities	2,525	2,850	4,379	3,131	4,131	-
Cash & Short-Term Investments	6,442	7,654	9,007	7,455	8,294	480.84
Cash Growth	-19.13%	-15.03%	20.83%	-10.12%	1624.84%	19.07%
Accounts Receivable	988.63	845.29	1,077	785.49	862.5	424.8
Other Receivables	212.64	218.91	236.3	329.18	458.17	595.89
Receivables	1,201	1,064	1,313	1,115	1,321	1,021
Inventory	1,453	1,434	1,559	1,597	1,216	992.41
Other Current Assets	313.28	403.35	246.61	179.06	159.22	180.64
Total Current Assets	9,410	10,556	12,126	10,346	10,990	2,675
Property, Plant & Equipment	4,355	4,151	3,550	2,225	1,462	1,463
Long-Term Investments	511.26	90.88	61.75	16.95	13.42	8.86
Goodwill	866.5	864.29	1,045	-	-	-
Other Intangible Assets	960.82	995.23	1,033	265.7	208.33	131.66
Long-Term Accounts Receivable	36.66	35.69	-	-	-	-
Long-Term Deferred Tax Assets	161.72	175.35	211.97	122.72	143.13	69.36
Long-Term Deferred Charges	125.41	131.09	132.69	174.79	121.34	165.47
Other Long-Term Assets	141.04	112.55	92.27	115.57	63.81	19
Total Assets	16,569	17,112	18,253	13,267	13,002	4,531
Accounts Payable	1,196	1,433	1,144	770.72	756	735.8
Accrued Expenses	480.68	543.05	714.42	448.46	264.91	120.71
Short-Term Debt	1,170	1,493	2,295	-	150.07	120
Current Portion of Long-Term Debt	180.13	20.14	8.01	-	-	5
Current Portion of Leases	193.48	202.66	207.31	216.18	-	-
Current Income Taxes Payable	36.23	40.19	197.57	80.63	415.53	36.92
Current Unearned Revenue	179.91	193.26	566.82	341.18	684.5	55.21
Other Current Liabilities	539.24	345.77	353.78	217.57	155.77	113.37
Total Current Liabilities	3,976	4,271	5,487	2,075	2,427	1,187
Long-Term Debt	-	170	-	-	-	134.21
Long-Term Leases	304.17	292.01	326.46	381.81	-	-
Long-Term Unearned Revenue	116.53	121.65	98.79	109.63	94.92	46.12
Long-Term Deferred Tax Liabilities	132.2	138.52	133.68	13.34	12.17	-
Other Long-Term Liabilities	-	-	-	-	-	0.59
Total Liabilities	4,538	5,002	6,055	2,580	2,534	1,368
Common Stock	588.29	594.39	426.49	426.49	426.49	376.49
Additional Paid-In Capital	3,939	4,381	4,546	4,550	4,482	948.91
Retained Earnings	7,122	7,029	7,246	5,958	5,547	1,835
Treasury Stock	-217.31	-473.55	-500.08	-257.99	-	-
Comprensive Income & Other	-0.72	2.22	0.78	-1.56	-1.11	0.04
Total Common Equity	11,431	11,533	11,720	10,675	10,454	3,160
Minority Interest	599.84	577.1	478.16	12.2	14.46	3.17
Shareholders' Equity	12,031	12,110	12,198	10,687	10,468	3,164
Total Liabilities & Equity	16,569	17,112	18,253	13,267	13,002	4,531
Total Debt	1,848	2,178	2,837	597.99	150.07	259.21
Net Cash (Debt)	4,594	5,476	6,170	6,857	8,144	221.63
Net Cash Growth	-16.89%	-11.25%	-10.01%	-15.80%	3574.47%	112.61%
Net Cash Per Share	7.78	9.25	10.43	11.50	14.95	0.42
Filing Date Shares Outstanding	582.33	583.94	587.63	587.63	597.09	527.09
Total Common Shares Outstanding	582.33	588.14	587.63	587.63	597.09	527.09
Working Capital	5,434	6,285	6,638	8,271	8,563	1,488
Book Value Per Share	19.63	19.61	19.94	18.17	17.51	6.00
Tangible Book Value	9,604	9,674	9,642	10,409	10,246	3,029
Tangible Book Value Per Share	16.49	16.45	16.41	17.71	17.16	5.75
Buildings	2,022	1,967	1,496	949.42	878.49	910.61
Machinery	2,194	1,983	1,863	1,238	1,119	872.61
Construction In Progress	1,030	984.57	765.01	216.1	61.38	187.81

Source: S&P Capital IQ. Standard template. Financial Sources.